226 related articles for article (PubMed ID: 12370703)
41. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
Le T; Leis A; Pahwa P; Wright K; Ali K; Reeder B; Hopkins L; Fung MF
Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
[TBL] [Abstract][Full Text] [Related]
43. Fatigue in breast cancer survivors: the impact of a mind-body medicine intervention.
Appling SE; Scarvalone S; MacDonald R; McBeth M; Helzlsouer KJ
Oncol Nurs Forum; 2012 May; 39(3):278-86. PubMed ID: 22543386
[TBL] [Abstract][Full Text] [Related]
44. Quality of life as a predictor of weight loss in obese, early-stage breast cancer survivors.
Darga LL; Magnan M; Mood D; Hryniuk WM; DiLaura NM; Djuric Z
Oncol Nurs Forum; 2007 Jan; 34(1):86-92. PubMed ID: 17562636
[TBL] [Abstract][Full Text] [Related]
45. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.
Roscoe JA; Morrow GR; Hickok JT; Mustian KM; Griggs JJ; Matteson SE; Bushunow P; Qazi R; Smith B
Breast Cancer Res Treat; 2005 Feb; 89(3):243-9. PubMed ID: 15754122
[TBL] [Abstract][Full Text] [Related]
46. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
Danaher EH; Ferrans C; Verlen E; Ravandi F; van Besien K; Gelms J; Dieterle N
Oncol Nurs Forum; 2006 May; 33(3):614-24. PubMed ID: 16676017
[TBL] [Abstract][Full Text] [Related]
47. The experience of fatigue in Turkish patients receiving chemotherapy.
Yurtsever S
Oncol Nurs Forum; 2007 May; 34(3):721-8. PubMed ID: 17573331
[TBL] [Abstract][Full Text] [Related]
48. Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer.
Wielgus KK; Berger AM; Hertzog M
Oncol Nurs Forum; 2009 Jan; 36(1):38-48. PubMed ID: 19136337
[TBL] [Abstract][Full Text] [Related]
49. Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation.
El-Banna MM; Berger AM; Farr L; Foxall MJ; Friesth B; Schreiner E
Oncol Nurs Forum; 2004 Sep; 31(5):937-44. PubMed ID: 15378094
[TBL] [Abstract][Full Text] [Related]
50. The effects of group exercise on fatigue and quality of life during cancer treatment.
Losito J; Murphy S; Thomas M
Oncol Nurs Forum; 2006 Jul; 33(4):821-5. PubMed ID: 16858464
[TBL] [Abstract][Full Text] [Related]
51. Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.
Zachariae R; Paulsen K; Mehlsen M; Jensen AB; Johansson A; von der Maase H
Psychother Psychosom; 2007; 76(6):376-84. PubMed ID: 17917474
[TBL] [Abstract][Full Text] [Related]
52. Energy for living with cancer: preliminary findings of a cancer rehabilitation group intervention study.
Holley S; Borger D
Oncol Nurs Forum; 2001 Oct; 28(9):1393-6. PubMed ID: 11683309
[TBL] [Abstract][Full Text] [Related]
53. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
Chang J; Couture F; Young S; McWatters KL; Lau CY
J Clin Oncol; 2005 Apr; 23(12):2597-605. PubMed ID: 15452188
[TBL] [Abstract][Full Text] [Related]
54. Effects of relaxation training on sleep quality and fatigue in patients with breast cancer undergoing adjuvant chemotherapy.
Demiralp M; Oflaz F; Komurcu S
J Clin Nurs; 2010 Apr; 19(7-8):1073-83. PubMed ID: 20492052
[TBL] [Abstract][Full Text] [Related]
55. Predictors of self-reported memory problems in patients with ovarian cancer who have received chemotherapy.
Myers JS; Sousa VD; Donovan HS
Oncol Nurs Forum; 2010 Sep; 37(5):596-603. PubMed ID: 20797951
[TBL] [Abstract][Full Text] [Related]
56. Prognostic impact of hemoglobin levels before and during carboplatin/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer.
Eichbaum MH; Weiss LM; Bruckner T; Schneeweiss A; Sinn HP; Gebauer G; Fersis N; Kussmaul J; Sohn C
Med Sci Monit; 2009 Apr; 15(4):CR156-63. PubMed ID: 19333199
[TBL] [Abstract][Full Text] [Related]
57. Self-reported comorbid conditions and medication usage in breast cancer survivors with and without lymphedema.
Ridner SH; Dietrich MS
Oncol Nurs Forum; 2008 Jan; 35(1):57-63. PubMed ID: 18192153
[TBL] [Abstract][Full Text] [Related]
58. Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.
Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; du Bois A;
J Clin Oncol; 2006 Feb; 24(4):579-86. PubMed ID: 16446330
[TBL] [Abstract][Full Text] [Related]
59. Fatigue during breast radiotherapy and its relationship to biological factors.
Wratten C; Kilmurray J; Nash S; Seldon M; Hamilton CS; O'Brien PC; Denham JW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):160-7. PubMed ID: 15093912
[TBL] [Abstract][Full Text] [Related]
60. Perspectives on living with ovarian cancer: older women's views.
Fitch MI; Gray RE; Franssen E
Oncol Nurs Forum; 2001 Oct; 28(9):1433-42. PubMed ID: 11683313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
